Sales of Zecuity Migraine Skin Patches Halted

June 14, 2016 -- Sales of the migraine treatment skin patch Zecuity have been halted after patients reported suffering burns and scars where the patches were applied, Teva Pharmaceutical says.


The Israel-based company also said consumers with the disposable battery-powered patches should stop using them, the Associated Press reported.


The patches are applied to the upper arm or thigh and deliver medicine through the skin to treat migraine headaches. But some users have developed severe redness, skin discoloration, cracked skin, and pain where patches were applied, according to the U.S. Food and Drug Administration.


Teva said it is recalling the patches and working with the FDA to determine the cause of the skin reactions, the AP reported.